Dense deposit disease associated with monoclonal gammopathy of undetermined significance.
about
Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GNPartial ADAMTS13 deficiency in atypical hemolytic uremic syndrome.A novel hybrid CFHR1/CFH gene causes atypical hemolytic uremic syndromeAnti-complement-factor H-associated glomerulopathies.Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complementChildhood-onset dense deposit disease: a rare cause of proteinuriaC3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.Current concepts in C3 glomerulopathy.Allelic variants of complement genes associated with dense deposit disease.C3 glomerulonephritis associated with monoclonal gammopathy: a case series.Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?Dense deposit disease in Korean children: a multicenter clinicopathologic study.Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits.Dense deposit disease and C3 glomerulopathyC3 glomerulopathy: consensus report.Idiopathic membranoproliferative glomerulonephritis: does it exist?Pathogenesis of the C3 glomerulopathies and reclassification of MPGN.Recent insights into C3 glomerulopathyKidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach.Paraprotein-Related Kidney Disease: Glomerular Diseases Associated with Paraproteinemias.Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins-What Determines the Site of Injury?Monoclonal gammopathy of renal significance: Diagnostic workup.C3 glomerulopathy associated to multiple myeloma successfully treated by autologous stem cell transplant.C3 glomerulopathy.Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity.C3 glomerulopathy and current dilemmas.Development of Renal Failure without Proteinuria in a Patient with Monoclonal Gammopathy of Undetermined Significance: An Unusual Presentation of AL Kappa Amyloidosis.C3 glomerulopathy in adults: a distinct patient subset showing frequent association with monoclonal gammopathy and poor renal outcome.Dysproteinemias and Glomerular Disease.How I manage monoclonal gammopathy of undetermined significance.Dominant C3 glomerulopathy: new roles for an old actor in renal pathology.Monoclonal gammopathy of renal significance (MGRS) increases the risk for progression to multiple myeloma: an observational study of 2935 MGUS patients.The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases.Anti-factor H antibody affecting factor H cofactor activity in a patient with dense deposit disease.Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report.Eculizumab as salvage therapy for recurrent monoclonal gammopathy-induced C3 glomerulopathy in a kidney allograft.
P2860
Q26741542-EEFC01B8-F1A0-4780-A538-289E1806A22DQ30543370-D1E0199A-F613-457C-82D4-99C344A2A778Q33409307-1A98D455-99DE-487A-9D6D-AF45DB42FC1BQ33434103-92BD8B76-9FF0-4E8D-9633-E0D97B09F703Q33849695-19D199DC-A71E-43C6-8B0A-4CA4B5C7761CQ33906517-06C3D59B-A976-4456-A195-1CCCC32560BEQ34295006-E5DA8F92-094E-487E-B587-D01FC345EF02Q34574482-69700915-4CB2-4ABE-B992-650ED49839F6Q35142753-1AA9F65D-A594-4D7F-8145-7C5CE29E41E8Q35618793-54D65940-925F-4739-9637-AE9A5A1D7851Q35983428-EDA43AA6-C5F1-4D00-AFB3-37EE4B5ABAEDQ36310131-0C48C25E-4FC3-4F7E-8B38-FA76A3B97118Q36394063-D90A78E0-A7B1-43D3-A4B5-94161A0010A1Q37286653-33B964F7-8A5E-4050-BA4B-D32C25EF88E8Q37348685-98EBEC17-FD92-4DE6-909F-9CF169447D9CQ38026540-DFF94DC9-B135-4B95-9DDC-3376C9B045E8Q38048606-7DFADBB6-9103-4967-B849-EF5B88625CAFQ38088187-E83864FD-4AD3-4D44-860C-3763B07D27E3Q38549182-0C41C823-6FF0-491A-9E41-9D71039E68EEQ38831139-F3E7AC5E-C483-4019-BC9F-E9798EB3CEAAQ38928153-1BEE7D90-A377-4506-9F12-6D4C921C3CB1Q39186665-830B0003-D042-473C-85BC-1EFBBF1A681CQ39207517-69D53328-99C7-4413-932C-B1EB69EEC8CAQ39207807-3F9DF75A-2CB1-40F6-912C-26D60411C5CFQ39251479-EF5B6E0E-5771-4ADC-9EBE-28B6273EE9D6Q40439038-757A9BAC-FDDF-4430-9D96-5AE8E2E196CEQ41915262-4CC16407-1466-4221-881D-424784EB24C5Q42113690-D853815A-B61F-4F49-ADBC-2123AE41EF6CQ47428714-67A88AD7-4C72-445F-8BEA-F881C3EEC918Q48221793-6BE04188-6C92-416A-878F-D63A8718BDBFQ48277312-C3D2DAF5-852D-45DD-9522-63786A3A3E1FQ50054682-7C8C64CD-AA59-49B0-BAB4-186E24BDABCDQ52716113-B61CD2DF-3D8C-4224-97E5-DB3DAA072D21Q55082090-B90C2F3B-0312-49C0-AD2A-B5F54BB636C0Q55361095-6C518C5A-681C-45C5-933C-C18C6160D592Q55450113-E561C512-689E-4C02-AF1C-0962D7FEAC69
P2860
Dense deposit disease associated with monoclonal gammopathy of undetermined significance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dense deposit disease associated with monoclonal gammopathy of undetermined significance.
@en
Dense deposit disease associated with monoclonal gammopathy of undetermined significance.
@nl
type
label
Dense deposit disease associated with monoclonal gammopathy of undetermined significance.
@en
Dense deposit disease associated with monoclonal gammopathy of undetermined significance.
@nl
prefLabel
Dense deposit disease associated with monoclonal gammopathy of undetermined significance.
@en
Dense deposit disease associated with monoclonal gammopathy of undetermined significance.
@nl
P2093
P2860
P1476
Dense deposit disease associated with monoclonal gammopathy of undetermined significance.
@en
P2093
Donna J Lager
Dylan V Miller
Fernando C Fervenza
Lynn D Cornell
Richard J H Smith
Sanjeev Sethi
Srivilliputtur G Santhana Krishnan
William R Sukov
Yuzhou Zhang
P2860
P304
P356
10.1053/J.AJKD.2010.06.021
P577
2010-09-15T00:00:00Z